Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis Landmark study using the Olink Explore platform identifes proteins in the blood that may provide a 7-year warning for various cancers.

Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics Novogene AMEA to begin offering Olink Explore HT high-throughput proteomics services to unravel the connections between genes, proteins, and diseases.

Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics Three landmark studies published in Nature demonstrate the power of Olink technology for understanding human biology.